We are live on ! Find out more
WS

Wedbush Securities Portfolio holdings

AUM $3.88B
1-Year Est. Return 32.38%
This Fund
S&P 500
This Quarter Est. Return
+10.07%
1 Year Est. Return
+32.38%
3 Year Est. Return
+99.93%
5 Year Est. Return
+115.9%
10 Year Est. Return
+395.26%
AUM
$1.04B
AUM Growth
-$14.7M
Cap. Flow
-$95.6M
Cap. Flow %
-9.17%
Top 10 Hldgs %
20.32%
Holding
1,067
New
108
Increased
299
Reduced
450
Closed
137

Sector Composition

Rank Sector Weight
1 Technology 18.4%
2 Healthcare 9.62%
3 Consumer Discretionary 9.35%
4 Financials 7.91%
5 Communication Services 6.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NSPR icon
851
InspireMD
NSPR
$32.1M
$73K 0.01%
15,367
+7,333
+91% +$46.5K
VVR icon
852
Invesco Senior Income Trust
VVR
$456M
$71K 0.01%
19,500
CALA
853
DELISTED
Calithera Biosciences, Inc
CALA
$71K 0.01%
+1,025
New +$89.4K
IGD
854
Voya Global Equity Dividend and Premium Opportunity Fund
IGD
$509M
$67K 0.01%
13,450
-12,401
-48% -$61.6K
NTBL
855
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
$66K 0.01%
1,557
+914
+142% +$40.3K
NVCN
856
DELISTED
Neovasc Inc.
NVCN
$66K 0.01%
1,234
-542
-31% -$31.3K
MITT
857
TPG Mortgage Investment Trust
MITT
$231M
$65K 0.01%
7,849
-7,494
-49% -$66.1K
OVID icon
858
Ovid Therapeutics
OVID
$427M
$63K 0.01%
+10,900
New +$72.9K
AMPE
859
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$63K 0.01%
220
-87
-28% -$21.6K
FPL
860
DELISTED
FIRST TRUST NEW OPPORTUNITIES MLP & ENERGY FUND
FPL
$62K 0.01%
17,340
-6,038
-26% -$24K
ISEE
861
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$62K 0.01%
+11,000
New +$52.5K
PPT
862
Franklin Premier Income Trust
PPT
$323M
$60K 0.01%
13,463
-15,250
-53% -$70.8K
CIK
863
Credit Suisse Asset Management Income Fund
CIK
$135M
$59K 0.01%
20,081
-3,035
-13% -$8.6K
SWN
864
DELISTED
Southwestern Energy Company
SWN
$59K 0.01%
25,000
NURO
865
DELISTED
NeuroMetrix, Inc. Common Stock
NURO
$59K 0.01%
4,355
+1,780
+69% +$26.9K
TLSA icon
866
Tiziana Life Sciences
TLSA
$123M
$57K 0.01%
+17,105
New +$66.6K
CLRB icon
867
Cellectar Biosciences
CLRB
$19.5M
$56K 0.01%
149
+15
+11% +$5.92K
AKTX
868
Akari Therapeutics
AKTX
$14.9M
$55K 0.01%
+39
New +$57.8K
MNOV icon
869
MediciNova
MNOV
$65.5M
$55K 0.01%
+10,500
New +$60.6K
NCV
870
Virtus Convertible & Income Fund
NCV
$376M
$55K 0.01%
3,016
-3,018
-50% -$56.5K
SER icon
871
Serina Therapeutics
SER
$31.5M
$55K 0.01%
+1,931
New +$68.9K
VCNX
872
DELISTED
Vaccinex, Inc. Common Stock
VCNX
$55K 0.01%
+148
New +$161K
APTX
873
DELISTED
Aptinyx Inc. Common Stock
APTX
$55K 0.01%
16,200
IMV
874
DELISTED
IMV Inc. Common Shares
IMV
$52K 0.01%
+1,160
New +$52.1K
ATAXZ
875
DELISTED
AMERICA FIRST TAX EXEMT INV LP
ATAXZ
$52K 0.01%
12,835

Similar funds

Wedbush Securities's Q3 2020 Portfolio in Review

As of Q3 2020, Wedbush Securities held 1,067 positions worth $1.04B, down 1.4% from $1.06B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Wedbush Securities withdrew a net $95.6M in Q3 2020, closing 137 positions and reducing 450 holdings. Its most notable exit was Invesco KBW High Dividend Yield Financial ETF, an estimated $810K position sold in full.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Wedbush Securities opened a new position in Nuveen Dynamic Municipal Opportunities Fund worth $5.08M.

  • Wedbush Securities's largest Q3 2020 buy was Nuveen Dynamic Municipal Opportunities Fund: 339,000 shares worth $5.08M.
  • Wedbush Securities added most to PIMCO Enhanced Short Maturity Active Exchange-Traded Fund in Q3 2020, an estimated $7.89M increase.
  • Wedbush Securities's biggest Q3 2020 reduction was Apple, cutting an estimated $16.5M.
  • Wedbush Securities fully exited Invesco KBW High Dividend Yield Financial ETF in Q3 2020, selling an estimated $810K.
  • Wedbush Securities's ten largest holdings make up 20% of its $1.04B portfolio in Q3 2020.
  • Wedbush Securities opened 108 new positions and closed 137 in Q3 2020.
  • Wedbush Securities's portfolio value fell 1.4% quarter-over-quarter to $1.04B.

Based on Wedbush Securities's 13F filing for Q3 2020, filed 20 Oct 2020.